Blog - Page 440 of 5677 - QualityStocks

WednesdayAug 21, 2024 9:00 am

D-Wave Quantum Inc. (NYSE: QBTS) Reports Strong Q2 2024 Results

The company reported a 28% increase in revenue, a 6% rise in bookings, a 97% improvement in GAAP gross profit and a 444% increase in cash, for the second quarter of 2024, on a year over year basis D-Wave's CEO, Dr. Alan Baratz, summarized the company's ongoing strategic direction and provided an expansive list of achievements Highlights mentioned include a quantum AI product development roadmap extending D-Wave’s Leap(TM) quantum cloud service, an expanded partnership with Zapata AI, new customer hybrid quantum applications, and more D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software, and services, and the first…

WednesdayAug 21, 2024 8:30 am

QualityStocksNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS), NTT DOCOMO Report on Quantum Optimization Pilot Program Resulting in 15% Improved Mobile Network Performance

D-Wave Quantum (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software and services, and the world’s first commercial supplier of quantum computers, has partnered with NTT DOCOMO Inc., Japan’s largest mobile phone operator, to work on a quantum optimization pilot that resulted in demonstrable mobile network performance improvements. According to the announcement, the project showed a reduction in network signal congestion across base stations, with potential for more efficient signal transmission and equipment cost savings. For the collaboration, DOCOMO used D-Wave’s annealing quantum computing solutions to reduce congestion at base stations by decreasing paging signals during peak calling times…

TuesdayAug 20, 2024 3:48 pm

QualityStocksNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) Quantum AI Product Roadmap Enhancements Highlighted in Syndicated Broadcast

D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software and services, and the world’s first commercial supplier of quantum computers, is featured in a NetworkNewsAudio (“NNA”) broadcast. NNA broadcasts are designed to provide additional visibility, recognition and brand awareness to the investment community. According to the broadcast, D-Wave is focused on strengthening the connection between quantum optimization, artificial intelligence (AI) and machine learning (ML). The company is working to accomplish this by extending its product development roadmap with enhancements to its Leap™ quantum cloud service. Three key areas are included in D-Wave’s product development roadmap extensions:…

TuesdayAug 20, 2024 1:39 pm

QualityStocksNewsBreaks – National Investment Banking Association Selects IBN as Official Media Sponsor for Its Landmark 150th Investment Conference

The National Investment Banking Association (“NIBA”) has selected IBN (“InvestorBrandNetwork”), a cutting-edge corporate communications and digital engagement platform providing tailored platform solutions for public and private companies, as an official media sponsor of its 150th Investment Conference. As an official media sponsor, IBN is leveraging its array of state-of-the-art solutions to heighten recognition of the event through an array of extensive digital channels, social media capabilities, and communication strategy. InvestorWire, a key distribution brand of IBN, will serve as the Official Newswire for the conference scheduled for September 4-5, 2024, at The Westin Fort Lauderdale Beach Resort, Fort Lauderdale, Florida.…

TuesdayAug 20, 2024 1:29 pm

QualityStocksNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Enters Into $2M Investment Commitment Agreement with Its Largest Existing Shareholder

Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharmaceutical company focused on developing inflammation and immunology (“I&I”) biological products and providing CDMO services through its Scinai Bioservices business unit, has entered into a $2 million Investment Commitment Agreement with RK Stone Miami LLC, an affiliate of the largest shareholder of the company, Mr. Daniel Stone. Under the terms of the agreement, Scinai may issue and sell ASDs to the investor, from time to time through December 31, 2024, for an aggregate purchase price of up to $2 million. The agreement does not require the company to register for resale the ADSs to be…

TuesdayAug 20, 2024 12:26 pm

QualityStocksNewsBreaks – Renforth Resources Inc. (CSE: RFR) (OTCQB: RFHRF) (FSE: 9RR) Shares Update on Completed, Upcoming Exploration Activities

Renforth Resources (CSE: RFR) (OTCQB: RFHRF) (FSE: 9RR) today updated shareholders on the completed summer exploration activities and those set to begin on its wholly owned Malartic Metals Package (“MMP”) property and its wholly owned Parbec gold deposit, both located in Malartic, Quebec. According to the update, work at the MMP property has identified the Victoria polymetallic system, extending from the surface to a drilled depth of approximately 200m, and led to the discovery of the Beaupré copper/silver zone, containing chalcopyrite, bornite and silver on the surface over approximately 175m in length. In addition, Renforth has completed an initial soil sampling…

TuesdayAug 20, 2024 11:01 am

QualityStocksNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Exciting INM-901 Data Providing ‘Attractive Therapeutic Approach’ in Alzheimer’s Treatment

InMed Pharmaceuticals (NASDAQ: INM), a leader in the manufacturing, development and commercialization of rare cannabinoids and proprietary cannabinoid analogs, today announced that recent data from preclinical studies confirms INM-901, a proprietary small molecule drug candidate, as an oral formulation that will be utilized in the company’s development programs for Alzheimer’s disease. The data shows that the INM-901 formulation can be administered orally and maintains similar drug exposure and therapeutic levels as intraperitoneal (“IP”) delivery over a 24-hour period in the brain. The announcement noted that the oral delivery method offers potential advantages such as lower treatment delivery costs. “We are…

TuesdayAug 20, 2024 9:00 am

Annovis Bio Inc. (NYSE: ANVS) CEO Discusses Findings of Buntanetap Phase 2/3 Alzheimer’s Study on the Bell2Bell Podcast

Annovis Bio’s lead drug candidate buntanetap has the potential to significantly improve the quality of life for early Alzheimer’s patients In a short-term Phase 2/3 study, buntanetap has been shown to work three times better than the standard of care in the market The company plans further clinical trials to validate the efficacy and safety of buntanetap in treating both Parkinson’s and Alzheimer’s diseases Annovis Bio (NYSE: ANVS), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases, presented significant data and findings of its Phase 2/3 Alzheimer’s study of lead drug candidate buntanetap at the Alzheimer’s Association…

MondayAug 19, 2024 1:24 pm

QualityStocksNewsBreaks – GivBux Inc. (GBUX) Marks Milestone in ‘Evolution of Corporation’ with Submission of Required Docs to SEC

GivBux (OTC: GBUX), a publicly traded Super App and charitable giving platform, has submitted its U.S. Securities and Exchange Commission (“SEC”) Form 10 along with required accompanying documents that are required to qualify as a fully reporting Required OTCQB Corporation. According to the announcement, GivBux has now submitted all documentation required to qualify as a fully-reporting OTCQB corporation. “We are very excited to announce this major milestone in the evolution of our corporation,” said GivBux president Umesh Tim Singh in the press release. “I want to commend our executive team for their hard work and diligence in accomplishing this task in such a…

Site Search

Company Search